Understand how clinical trial costs and insurance coverage work.
You never pay for the experimental treatment itself. The sponsoring company or institution provides the drug at no cost to you. That is true of all legitimate clinical trials.
Once the trial ends, things get more complicated (see below). While you are in the trial, the drug is free.
Many trials cover the cost of visits, lab work, scans, and other tests related to the trial. They should. Coverage varies, however, and you should ask before enrolling. Some trials cover everything. Some cover some things. Some ask the participant's insurance to cover certain things.
This is why you ask, in detail, what costs the trial covers and what your insurance will be billed for.
Many trials also reimburse travel, parking, or meals. Ask about this too. If you're traveling to a distant trial site, reimbursement can matter.
Reimbursement schedules vary by trial, but typical ranges help with planning. Travel by car is usually reimbursed at the IRS standard mileage rate (around 67 cents per mile in recent years, updated annually). Air travel for distant sites is typically full coach airfare. Parking and tolls are reimbursed with receipts. Meals during travel days are typically $25 to $75 per day. Lodging for multi-night visits runs $150 to $300 per night, or actual cost if the trial site arranges a covered hotel.
Per-visit stipends to compensate your time and travel range from $25 to $200 per visit, with longer or more invasive visits at the higher end. Many trials now offer childcare reimbursement, typically $100 to $200 per day. The full reimbursement schedule should appear in the informed consent document; ask the research coordinator for it before enrolling, not after.
These are typical ranges, not guarantees. Some trials reimburse generously, others sparingly, and a small number expect participants to absorb travel costs. For multi-year rare disease trials at distant academic centers, the difference between full and partial reimbursement can be thousands of dollars.
Several established nonprofit programs cover trial-related costs that the sponsor doesn't reimburse. The major ones every rare disease patient should know about:
Patient Advocate Foundation (PAF) provides case management and copay assistance for patients with chronic, life-threatening, or debilitating conditions. Eligibility is typically up to 400% of federal poverty level. PAF case managers can help locate other assistance programs and resolve insurance disputes around trial-related care.
The PAN Foundation offers disease-specific copay funds. Funds open and close based on available donor money, so checking the open-fund list near your enrollment date matters. HealthWell Foundation operates similarly with different disease-specific funds and income criteria.
NORD's Patient Assistance Programs cover medication costs, insurance premiums, and travel for over 100 rare diseases. The National Patient Travel Center coordinates free or reduced air travel for patients reaching distant trial sites. Mercy Medical Angels covers ground transportation.
Many drug manufacturers also run trial-specific patient support programs that cover travel, lodging, and ancillary costs even before the drug is approved. Ask the research coordinator at enrollment which programs the sponsor partners with for this trial; trial sites often have a financial counselor who can run applications for you.
Your health insurance is required to cover standard care and routine medical costs while you're in an approved clinical trial. The Affordable Care Act mandates this for most plans, and the 2014 expansion extended the requirement to Medicaid programs in all 50 states. If you need blood work to check for side effects, insurance covers it. If you need imaging to monitor the trial's effectiveness, insurance covers it. If you need a procedure that you would have needed anyway as part of standard care for your condition, insurance covers it.
The one consistent exception is the experimental drug itself, which is never billed to insurance. The trial sponsor provides it.
State Medicaid implementation of the 2014 ACA mandate varies. Some state Medicaid programs cover everything routine without question; others have implemented restrictive interpretations that exclude certain visit types or require pre-authorization for each trial. The Kaiser Family Foundation tracks state-by-state Medicaid clinical trial coverage policies, and your disease-specific advocacy organization typically has the most current practical information about real-world coverage in your state.
Where you enroll affects your insurance bills too. Academic medical centers bill at higher facility-fee rates than community-based trial sites, so the same standard-of-care visit can be billed at $200 at a community oncology practice and $1,200 at a major teaching hospital. If a trial is offered at multiple sites, ask each site's billing office for an estimate of out-of-pocket costs at that location before choosing.
Trial-related stipends paid to participants and caregivers are generally taxable income. If the total stipend exceeds $600 in a calendar year, the trial sponsor will issue a 1099-MISC at year end, and you'll report the income on your federal tax return. Travel reimbursements that match documented expenses (mileage, parking, meals) are generally non-taxable, but per diem amounts that exceed your actual expenses may be taxable.
Out-of-pocket trial-related medical expenses (visits not covered by the sponsor, lodging beyond reimbursement caps) may qualify for the medical expense deduction on Schedule A if your total medical expenses exceed 7.5% of adjusted gross income.
Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs) can typically be used for trial-related expenses that meet IRS qualified medical expense definitions, including some travel costs for medically necessary care. Your plan administrator can confirm what's eligible. IRS Publication 502 lists every qualified expense category.
What happens after the trial is one of the most important questions to ask before enrolling. Several pathways may apply, and they depend on whether the drug worked for you and whether the trial moved toward FDA approval.
Open-label extension trials are continuations of the original trial in which everyone, including patients who got placebo, receives the active drug after the blinded portion ends. Many late-stage rare disease trials build these in. Ask whether one exists for your trial before enrolling, since it materially changes the access picture.
FDA Expanded Access (also called compassionate use) lets patients with serious or life-threatening conditions access investigational drugs outside of a clinical trial. Your physician submits FDA Form 3926 on your behalf. The FDA approves over 99% of expanded access requests it receives, but the manufacturer still has to agree to provide the drug, and not all do.
Right to Try Act of 2018 is a federal law that creates an alternate pathway for terminally ill patients to access investigational drugs that have completed Phase 1 testing. Right to Try bypasses the FDA, but the manufacturer still has to agree, and the law has been used in fewer than 100 documented cases since enactment.
Named patient programs (sometimes called managed access programs) are sponsor-run programs that provide drugs to specific patients on a case-by-case basis after trial completion but before FDA approval. These are more common for rare disease trials than for common-condition trials.
The simplest path is FDA approval followed by standard prescription access. If the trial leads to approval and the drug works for you, you transition to normal pharmacy and insurance coverage. The other pathways exist for patients who responded during the trial but the drug is not yet approved, or for patients with conditions where formal approval may take years.
The investigational drug or device in a clinical trial is always provided at no cost to the patient. Most trials also cover protocol-specific tests, study visits, and procedures that would not be part of standard care. Routine medical care that the patient would have needed anyway is typically billed to insurance under the Affordable Care Act clinical trial coverage mandate. Out-of-pocket costs vary by trial and location, but most rare disease trials aim to minimize patient financial burden.
Yes. Under the Affordable Care Act, most U.S. health insurance plans are required to cover routine medical costs for participants in approved clinical trials. The 2014 ACA expansion extended this requirement to Medicaid programs in all 50 states. Routine costs include doctor visits, lab work, imaging, and procedures that you would have needed regardless of trial participation. The experimental drug itself is never billed to insurance because the sponsor provides it free.
Yes, clinical trial stipends paid to participants are generally taxable income. If a stipend exceeds $600 in a calendar year, the trial sponsor will issue a 1099-MISC form, and the income must be reported on the federal tax return. Travel reimbursements that match documented expenses (mileage, parking, meals) are generally non-taxable, but per diem amounts that exceed actual expenses may be taxable.
Typical clinical trial travel reimbursement includes the IRS standard mileage rate for car travel (around 67 cents per mile), full coach airfare for distant sites, $25 to $75 per day for meals during travel, and $150 to $300 per night for lodging or actual cost if the trial site arranges a covered hotel. Per-visit stipends to compensate for time and travel range from $25 to $200, with longer or more invasive visits at the higher end. Specific amounts must be disclosed in the informed consent form.
Continued access to a clinical trial drug after the study ends depends on the sponsor and the regulatory pathway. Many trials offer an open-label extension where all participants (including those on placebo) receive the active drug. After approval, the drug becomes available through standard pharmacy and insurance. Before approval, FDA Expanded Access (compassionate use) and the Right to Try Act provide alternate pathways for patients with serious conditions who responded to the drug but cannot continue through a trial.
Several patient assistance programs help with clinical trial costs. The Patient Advocate Foundation offers case management and copay help. The PAN Foundation and HealthWell Foundation operate disease-specific copay funds. NORD Patient Assistance Programs cover medication costs and travel for over 100 rare diseases. The National Patient Travel Center coordinates free or reduced air travel. Mercy Medical Angels covers ground transportation. Many drug manufacturers also run trial-specific patient support programs covering travel, lodging, and ancillary costs.
Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs) can typically be used for clinical trial-related expenses that meet IRS qualified medical expense definitions, including some travel costs for medically necessary care. IRS Publication 502 lists every qualified expense category. Plan administrators can confirm what is eligible under specific HSA and FSA plans, and out-of-pocket trial expenses may also qualify for the medical expense deduction on Schedule A if total medical expenses exceed 7.5% of adjusted gross income.